EMEA (Europe, Middle East and Africa) Insomnia Drugs Market Report 2017

August 2017 | 115 pages | ID: E4EBB6321FDEN
QYResearch

Abstracts

In this report, the EMEA Insomnia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Insomnia Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insomnia Drugs market competition by top manufacturers/players, with Insomnia Drugs sales volume (MT), price (K USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Eisai
• Pfizer
• Sanofi
• Takeda Pharmaceutical
• ECR Pharmaceuticals (Valeant)
• Vanda Pharmaceuticals
• Astellas
• Dainippon Sumitomo
• Flynn Pharma
• Johnson & Johnson
• Meda
• Somnus Therapeutics
• Purdue Pharma
• Neurim
• Minerva Neurosciences
• Pernix Therapeutics
• SkyePharma
• Paratek Pharmaceuticals

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (K USD/Kg), market share and growth rate of each type, primarily split into

• By Pharmacological
• Prescription Drugs
• Over-the-counter Drugs
• By Form
• Pills
• Capsules
• By Medications
• Antihistamines
• Melatonin
• Antidepressants
• Benzodiazepines
• Antipsychotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Insomnia Drugs for each application, including

• Hospital
• Ambulatory Surgical Center
• Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Insomnia Drugs Market Report 2017

1 INSOMNIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Insomnia Drugs
1.2 Classification of Insomnia Drugs
  1.2.1 EMEA Insomnia Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Insomnia Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Prescription Drugs
  1.2.4 Over-the-counter Drugs
1.3 EMEA Insomnia Drugs Market by Application/End Users
  1.3.1 EMEA Insomnia Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Ambulatory Surgical Center
  1.3.4 Home Care
1.4 EMEA Insomnia Drugs Market by Region
  1.4.1 EMEA Insomnia Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insomnia Drugs (2012-2022)
  1.5.1 EMEA Insomnia Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Insomnia Drugs Revenue and Growth Rate (2012-2022)

2 EMEA INSOMNIA DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Insomnia Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Insomnia Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Insomnia Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Insomnia Drugs Sale Price by Players (2012-2017)
2.2 EMEA Insomnia Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Insomnia Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Insomnia Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Insomnia Drugs Sale Price by Type (2012-2017)
2.3 EMEA Insomnia Drugs (Volume) by Application
2.4 EMEA Insomnia Drugs (Volume and Value) by Region
  2.4.1 EMEA Insomnia Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Insomnia Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Insomnia Drugs Sales Price by Region (2012-2017)

3 EUROPE INSOMNIA DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Insomnia Drugs Sales and Value (2012-2017)
  3.1.1 Europe Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Insomnia Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Insomnia Drugs Sales and Market Share by Type
3.3 Europe Insomnia Drugs Sales and Market Share by Application
3.4 Europe Insomnia Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Insomnia Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Insomnia Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Insomnia Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Insomnia Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Insomnia Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Insomnia Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Insomnia Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Insomnia Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INSOMNIA DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Insomnia Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Insomnia Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Insomnia Drugs Sales and Market Share by Type
4.3 Middle East Insomnia Drugs Sales and Market Share by Application
4.4 Middle East Insomnia Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Insomnia Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Insomnia Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Insomnia Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Insomnia Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Insomnia Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Insomnia Drugs Sales and Growth Rate (2012-2017)

5 AFRICA INSOMNIA DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Insomnia Drugs Sales and Value (2012-2017)
  5.1.1 Africa Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Insomnia Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Insomnia Drugs Sales and Market Share by Type
5.3 Africa Insomnia Drugs Sales and Market Share by Application
5.4 Africa Insomnia Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Insomnia Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Insomnia Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Insomnia Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Insomnia Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Insomnia Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Insomnia Drugs Sales and Growth Rate (2012-2017)

6 EMEA INSOMNIA DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insomnia Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eisai
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Insomnia Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eisai Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Insomnia Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Insomnia Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Takeda Pharmaceutical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Insomnia Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takeda Pharmaceutical Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 ECR Pharmaceuticals (Valeant)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Insomnia Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Vanda Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Insomnia Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Vanda Pharmaceuticals Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Astellas
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Insomnia Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astellas Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dainippon Sumitomo
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Insomnia Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dainippon Sumitomo Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Flynn Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Insomnia Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Flynn Pharma Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Meda
6.13 Somnus Therapeutics
6.14 Purdue Pharma
6.15 Neurim
6.16 Minerva Neurosciences
6.17 Pernix Therapeutics
6.18 SkyePharma
6.19 Paratek Pharmaceuticals

7 INSOMNIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Insomnia Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insomnia Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insomnia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insomnia Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INSOMNIA DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Insomnia Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Insomnia Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Insomnia Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Insomnia Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Insomnia Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Insomnia Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Insomnia Drugs
Figure EMEA Insomnia Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Insomnia Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Prescription Drugs Product Picture
Figure Over-the-counter Drugs Product Picture
Figure EMEA Insomnia Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Insomnia Drugs by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Ambulatory Surgical Center Examples
Table Key Downstream Customer in Ambulatory Surgical Center
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure EMEA Insomnia Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Insomnia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Insomnia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Insomnia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Insomnia Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Insomnia Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Insomnia Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Insomnia Drugs Sales Share by Players (2012-2017)
Figure 2016 Insomnia Drugs Sales Share by Players
Figure 2017 Insomnia Drugs Sales Share by Players
Figure EMEA Insomnia Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Insomnia Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Insomnia Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Insomnia Drugs Revenue Share by Players
Table 2017 EMEA Insomnia Drugs Revenue Share by Players
Table EMEA Insomnia Drugs Sale Price (K USD/Kg) by Players (2012-2017)
Table EMEA Insomnia Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Insomnia Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Insomnia Drugs by Type (2012-2017)
Figure EMEA Insomnia Drugs Sales Market Share by Type (2012-2017)
Table EMEA Insomnia Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Insomnia Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insomnia Drugs by Type in 2016
Table EMEA Insomnia Drugs Sale Price (K USD/Kg) by Type (2012-2017)
Table EMEA Insomnia Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Insomnia Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Insomnia Drugs by Application (2012-2017)
Figure EMEA Insomnia Drugs Sales Market Share by Application in 2016
Table EMEA Insomnia Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Insomnia Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Insomnia Drugs by Region (2012-2017)
Figure EMEA Insomnia Drugs Sales Market Share in 2016
Table EMEA Insomnia Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Insomnia Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Insomnia Drugs by Region (2012-2017)
Figure EMEA Insomnia Drugs Revenue Market Share Regions in 2016
Table EMEA Insomnia Drugs Sales Price (K USD/Kg) by Region (2012-2017)
Figure Europe Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Insomnia Drugs Revenue and Growth Rate (2012-2017)
Table Europe Insomnia Drugs Sales (MT) by Type (2012-2017)
Table Europe Insomnia Drugs Market Share by Type (2012-2017)
Figure Europe Insomnia Drugs Market Share by Type in 2016
Table Europe Insomnia Drugs Sales (MT) by Application (2012-2017)
Table Europe Insomnia Drugs Market Share by Application (2012-2017)
Figure Europe Insomnia Drugs Market Share by Application in 2016
Table Europe Insomnia Drugs Sales (MT) by Countries (2012-2017)
Table Europe Insomnia Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Insomnia Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Insomnia Drugs Sales Market Share by Countries in 2016
Table Europe Insomnia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Insomnia Drugs Revenue Market Share by Countries in 2016
Figure Germany Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Insomnia Drugs Sales (MT) by Type (2012-2017)
Table Middle East Insomnia Drugs Market Share by Type (2012-2017)
Figure Middle East Insomnia Drugs Market Share by Type (2012-2017)
Table Middle East Insomnia Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Insomnia Drugs Market Share by Applications (2012-2017)
Figure Middle East Insomnia Drugs Sales Market Share by Application in 2016
Table Middle East Insomnia Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Insomnia Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Insomnia Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Insomnia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Insomnia Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Insomnia Drugs Sales (MT) by Type (2012-2017)
Table Africa Insomnia Drugs Sales Market Share by Type (2012-2017)
Figure Africa Insomnia Drugs Sales Market Share by Type (2012-2017)
Figure Africa Insomnia Drugs Sales Market Share by Type in 2016
Table Africa Insomnia Drugs Sales (MT) by Application (2012-2017)
Table Africa Insomnia Drugs Sales Market Share by Application (2012-2017)
Figure Africa Insomnia Drugs Sales Market Share by Application (2012-2017)
Table Africa Insomnia Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Insomnia Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Insomnia Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Insomnia Drugs Sales Market Share by Countries in 2016
Table Africa Insomnia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Insomnia Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Insomnia Drugs Revenue Market Share by Countries in 2016
Figure South Africa Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Table Merck Insomnia Drugs Basic Information List
Table Merck Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Eisai Insomnia Drugs Basic Information List
Table Eisai Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Eisai Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eisai Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Eisai Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Insomnia Drugs Basic Information List
Table Pfizer Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Insomnia Drugs Basic Information List
Table Sanofi Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Insomnia Drugs Basic Information List
Table Takeda Pharmaceutical Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table ECR Pharmaceuticals (Valeant) Insomnia Drugs Basic Information List
Table ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Vanda Pharmaceuticals Insomnia Drugs Basic Information List
Table Vanda Pharmaceuticals Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Astellas Insomnia Drugs Basic Information List
Table Astellas Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Astellas Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Astellas Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Dainippon Sumitomo Insomnia Drugs Basic Information List
Table Dainippon Sumitomo Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Dainippon Sumitomo Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Dainippon Sumitomo Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Dainippon Sumitomo Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Flynn Pharma Insomnia Drugs Basic Information List
Table Flynn Pharma Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Flynn Pharma Insomnia Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Flynn Pharma Insomnia Drugs Sales Market Share in EMEA (2012-2017)
Figure Flynn Pharma Insomnia Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Insomnia Drugs Basic Information List
Table Meda Insomnia Drugs Basic Information List
Table Somnus Therapeutics Insomnia Drugs Basic Information List
Table Purdue Pharma Insomnia Drugs Basic Information List
Table Neurim Insomnia Drugs Basic Information List
Table Minerva Neurosciences Insomnia Drugs Basic Information List
Table Pernix Therapeutics Insomnia Drugs Basic Information List
Table SkyePharma Insomnia Drugs Basic Information List
Table Paratek Pharmaceuticals Insomnia Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insomnia Drugs
Figure Manufacturing Process Analysis of Insomnia Drugs
Figure Insomnia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Insomnia Drugs Major Manufacturers in 2016
Table Major Buyers of Insomnia Drugs
Table Distributors/Traders List
Figure EMEA Insomnia Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Insomnia Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Insomnia Drugs Price (K USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Insomnia Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Insomnia Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Insomnia Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Insomnia Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Insomnia Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Insomnia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Insomnia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Insomnia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Insomnia Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Insomnia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Insomnia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Insomnia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Insomnia Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Insomnia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Insomnia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Insomnia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Insomnia Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Insomnia Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Insomnia Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Insomnia Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources